We are live on ! Find out more
CAL

Capital Analysts LLC Portfolio holdings

AUM $4.34B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+184.17%
AUM
$1.05B
AUM Growth
+$101M
Cap. Flow
+$43.1M
Cap. Flow %
4.1%
Top 10 Hldgs %
42.07%
Holding
771
New
70
Increased
261
Reduced
141
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 7.68%
2 Healthcare 5.32%
3 Financials 3.58%
4 Consumer Discretionary 3.1%
5 Industrials 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
126
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.52M 0.14%
19,550
+4,650
+31% +$320K
SSNC icon
127
SS&C Technologies
SSNC
$18.6B
$1.52M 0.14%
25,060
+1,716
+7% +$103K
ADI icon
128
Analog Devices
ADI
$190B
$1.51M 0.14%
12,938
-607
-4% -$71.1K
CCI icon
129
Crown Castle
CCI
$32.2B
$1.51M 0.14%
9,058
+8,077
+823% +$1.33M
RSPU icon
130
Invesco S&P 500 Equal Weight Utilities ETF
RSPU
$533M
$1.51M 0.14%
31,968
+440
+1% +$20.9K
FMC icon
131
FMC
FMC
$1.33B
$1.5M 0.14%
14,201
+879
+7% +$94.1K
NFLX icon
132
Netflix
NFLX
$309B
$1.5M 0.14%
30,080
+1,910
+7% +$95.1K
FISV
133
Fiserv Inc
FISV
$27.9B
$1.47M 0.14%
+14,288
New +$1.42M
FM
134
DELISTED
iShares Frontier and Select EM ETF
FM
$1.45M 0.14%
56,817
-2,829
-5% -$69.9K
VYM icon
135
Vanguard High Dividend Yield ETF
VYM
$83.5B
$1.44M 0.14%
17,756
-411
-2% -$33.7K
MET icon
136
MetLife
MET
$62.1B
$1.44M 0.14%
38,621
+926
+2% +$35.1K
CVS icon
137
CVS Health
CVS
$122B
$1.43M 0.14%
24,468
-342
-1% -$21.3K
BAC icon
138
Bank of America
BAC
$442B
$1.39M 0.13%
57,779
+5,155
+10% +$128K
IJR icon
139
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.39M 0.13%
19,778
-7,550
-28% -$541K
CCMP
140
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.37M 0.13%
9,594
+608
+7% +$90.7K
HYDW icon
141
Xtrackers Low Beta High Yield Bond ETF
HYDW
$67.5M
$1.36M 0.13%
27,309
-1,748
-6% -$87.4K
IP icon
142
International Paper
IP
$22B
$1.35M 0.13%
35,254
+243
+0.7% +$8.58K
CFG icon
143
Citizens Financial Group
CFG
$30.6B
$1.34M 0.13%
53,156
-424
-0.8% -$10.8K
DHS icon
144
WisdomTree US High Dividend Fund
DHS
$1.58B
$1.32M 0.13%
21,067
-195
-0.9% -$12.4K
DVYE icon
145
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$1.3M 0.12%
43,278
-2,173
-5% -$69.4K
NOC icon
146
Northrop Grumman
NOC
$81.2B
$1.28M 0.12%
4,050
+200
+5% +$65.2K
OMER icon
147
Omeros
OMER
$959M
$1.2M 0.11%
118,767
+44,702
+60% +$576K
STZ icon
148
Constellation Brands
STZ
$23.2B
$1.19M 0.11%
6,269
+522
+9% +$95.2K
BSX icon
149
Boston Scientific
BSX
$71.5B
$1.17M 0.11%
30,538
+2,403
+9% +$92.6K
EXC icon
150
Exelon
EXC
$47B
$1.14M 0.11%
44,613
+184
+0.4% +$4.88K

Similar funds

Capital Analysts LLC's Q3 2020 Portfolio in Review

As of Q3 2020, Capital Analysts LLC held 771 positions worth $1.05B, up 11% from $952M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Capital Analysts LLC deployed $43.1M of net new capital in Q3 2020, opening 70 new positions and adding to 261 existing holdings. Its largest new stake was Fiserv Inc: 14,288 shares worth $1.47M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Chubb, an estimated $2.41M trimmed.

  • Capital Analysts LLC's largest Q3 2020 buy was Fiserv Inc: 14,288 shares worth $1.47M.
  • Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q3 2020, an estimated $6.91M increase.
  • Capital Analysts LLC's biggest Q3 2020 reduction was Chubb, cutting an estimated $2.41M.
  • Capital Analysts LLC fully exited State Street SPDR S&P Biotech ETF in Q3 2020, selling an estimated $168K.
  • Capital Analysts LLC's ten largest holdings make up 42% of its $1.05B portfolio in Q3 2020.
  • Capital Analysts LLC opened 70 new positions and closed 14 in Q3 2020.
  • Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $1.05B.

Based on Capital Analysts LLC's 13F filing for Q3 2020, filed 12 Nov 2020.